Relevant Literature: Waldenstrom's Macroglobulinemia

mSMART Consensus: Waldenstrom Macroglobulinemia (Kapoor 2017)

Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management (Gertz 2021)

Predictors of symptomatic hyperviscosity in Waldenström macroglobulinemia (Abeykoon 2018)

Assessment of fixed-duration therapies for treatment-naïve Waldenström macroglobulinemia (Abeykoon 2021)

Impact of MYD88L265P mutation status on histological transformation of Waldenström Macroglobulinemia (Zanwar 2019)

MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia (Abeykoon 2018)

Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic Review (Kyle 2018)

Ibrutinib monotherapy outside of clinical trial setting in Waldenström macroglobulinaemia: practice patterns, toxicities and outcomes (Abeykoon 2018)